MediWound Ltd. (MDWD)
NASDAQ: MDWD · Real-Time Price · USD
16.78
+0.98 (6.20%)
Nov 20, 2024, 4:00 PM EST - Market closed
MediWound Market Cap
MediWound has a market cap or net worth of $181.06 million as of November 21, 2024. Its market cap has increased by 149.05% in one year.
Market Cap
181.06M
Enterprise Value
158.20M
1-Year Change
149.05%
Ranking
Category
Stock Price
$16.78
Market Cap Chart
Since March 20, 2014, MediWound's market cap has decreased from $352.30M to $181.06M, a decrease of -48.61%. That is a compound annual growth rate of -6.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 20, 2024 | 154.90M | 65.14% |
| Dec 29, 2023 | 93.80M | 19.49% |
| Dec 30, 2022 | 78.50M | 22.08% |
| Dec 31, 2021 | 64.30M | -36.15% |
| Dec 31, 2020 | 100.70M | 19.45% |
| Dec 31, 2019 | 84.30M | -23.22% |
| Dec 31, 2018 | 109.80M | -8.58% |
| Dec 29, 2017 | 120.10M | 19.98% |
| Dec 30, 2016 | 100.10M | -45.60% |
| Dec 31, 2015 | 184.00M | 35.39% |
| Dec 31, 2014 | 135.90M | -61.42% |
| Mar 20, 2014 | 352.30M | - |
View and export this data all the way back to 2014.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Galectin Therapeutics | 172.91M |
| Stereotaxis | 172.42M |
| Actuate Therapeutics | 172.12M |
| Adaptimmune Therapeutics | 171.07M |
| Lineage Cell Therapeutics | 169.12M |
| Greenwich LifeSciences | 168.78M |
| 2seventy bio | 165.86M |
| The Joint | 164.07M |